|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200056821 |
|
最近更新日期: Date of Last Refreshed on: |
2022-10-08 21:00:22 |
|
注册时间: Date of Registration: |
2022-02-18 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 血液病患者铁含量检测及影响因素研究 |
|
Public title: |
Detection of iron content in patients with hematological diseases and its influencing factors |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
铁过载血液病患者铁含量检测及影响因素研究 |
|
Scientific title: |
Detection of iron content in iron overload patients with hematological diseases and its influencing factors |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张耀 |
研究负责人: |
常春康 |
|
Applicant: |
Zhang Yao |
Study leader: |
Chang Chunkang |
|
申请注册联系人电话: Applicant telephone: |
+86 18930174688 |
研究负责人电话:
Study leader's |
+86 18930177640 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zy13117091978zy@163.com |
研究负责人电子邮件: Study leader's E-mail: |
changchunkang@sjtu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市徐汇区宜山路600号 |
研究负责人通讯地址: |
上海市徐汇区宜山路600号 |
|
Applicant address: |
600 Yishan Road, Xuhui District, Shanghai |
Study leader's address: |
600 Yishan Road, Xuhui District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海交通大学附属上海市第六人民医院 |
||
|
Applicant's institution: |
Shanghai Sixth People's Hospital, Shanghai Jiao Tong University |
||
|
研究负责人所在单位: |
上海交通大学附属上海市第六人民医院 |
||
|
Affiliation of the Leader: |
Shanghai Sixth People's Hospital, Shanghai Jiao Tong University |
||
|
是否获伦理委员会批准: |
否 |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
上海交通大学附属上海市第六人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Sixth People's Hospital, Shanghai Jiao Tong University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市徐汇区宜山路600号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
600 Yishan Road, Xuhui District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金(号82070129) |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (numbers 82070129) |
||||||||||||||||||||||
|
研究疾病: |
血液病 |
||||||||||||||||||||||
|
Target disease: |
hemopathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
病例研究 |
||||||||||||||||||||||
|
Study design: |
Case study |
||||||||||||||||||||||
|
研究目的: |
分析合并铁过载的血液病患者铁代谢指标,肝脏、心脏、胰腺等脏器铁含量对器官功能及疾病的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
To analyze the iron metabolism indexes of hemopathy patients combined with iron overload, and the influence of iron content in liver, heart and pancreas on the function of these organs and their own diseases. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
长期输血依赖或合并铁代谢异常的血液病患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Hemopathy patients with long-term blood transfusion dependence or abnormal iron metabolism. |
||||||||||||||||||||||
|
排除标准: |
合并严重感染,非血液系统恶性肿瘤患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients with severe infection and non hematological malignancies. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-02-01 00:00:00至 To 2024-02-29 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-02-21 00:00:00 至 To 2024-02-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
课题组成员通过查找已出院和住院患者病历的方法产生随机序列 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The members of the research group generate random sequences by searching the medical records of discharged and hospitalized patients |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024年8月30日 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2024-8-30 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |